Hospital admissions for skin and soft tissue infections in a population with endemic scabies: A prospective study in Fiji, 2018-2019.


Journal

PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488

Informations de publication

Date de publication:
12 2020
Historique:
received: 07 07 2020
accepted: 13 10 2020
revised: 21 12 2020
pubmed: 10 12 2020
medline: 23 2 2021
entrez: 9 12 2020
Statut: epublish

Résumé

Scabies is an important predisposing factor for impetigo but its role in more serious skin and soft tissue infections (SSTIs) is not well understood. Information is limited on incidence of SSTIs in the presence of endemic scabies. We conducted a prospective study of hospital admissions for SSTIs in the Northern Division of Fiji (population: 131,914). Prospective surveillance for admissions with impetigo, abscess, cellulitis, wound infection, pyomyositis, necrotizing fasciitis, infected scabies, and crusted scabies was conducted at the Division's referral hospital between 2018 to 2019. Information was collected on demographic characteristics, clinical features, microbiology, treatment and outcomes. Over the study period, 788 SSTI admissions were recorded corresponding to a population incidence 647 per 100,000 person-years (95%CI 571-660). Incidence was highest at the extremes of age with peak incidence in children aged <5 years (908 per 100,000) and those aged ≥65 years (1127 per 100,000). Incidence was 1.7 times higher among the Indigenous Fijian population (753 per 100,000) compared to other ethnicities (442 per 100,000). Overall case fatality rate was 3.3%, and 10.8% for those aged ≥65 years. Scabies was diagnosed concurrently in 7.6% of all patients and in 24.6% of admitted children <5 years. There is a very high burden of hospital admissions for SSTIs in Fiji compared to high-income settings especially among the youngest, oldest and indigenous population which is concordant with scabies and impetigo distribution in this population. Our findings highlight the need for strategies to reduce the burden of SSTIs in Fiji and similar settings.

Identifiants

pubmed: 33296378
doi: 10.1371/journal.pntd.0008887
pii: PNTD-D-20-01232
pmc: PMC7752096
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0008887

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

JAMA Dermatol. 2017 May 1;153(5):406-412
pubmed: 28249066
Lancet Infect Dis. 2015 Aug;15(8):960-7
pubmed: 26088526
Aust J Rural Health. 2019 Dec;27(6):550-556
pubmed: 31880053
Trop Doct. 2014 Apr;44(2):77-81
pubmed: 24322764
PLoS Negl Trop Dis. 2015 Mar 04;9(3):e0003452
pubmed: 25738499
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
Diagn Microbiol Infect Dis. 2007 Jan;57(1):7-13
pubmed: 17059876
PLoS One. 2015 Aug 28;10(8):e0136789
pubmed: 26317533
BMC Infect Dis. 2015 Aug 21;15:362
pubmed: 26293161
Epidemiol Infect. 2011 Nov;139(11):1794-804
pubmed: 21156094
BMC Infect Dis. 2017 Jun 7;17(1):405
pubmed: 28592231
Curr Opin Infect Dis. 2019 Apr;32(2):77-86
pubmed: 30664027
BMC Infect Dis. 2014 Mar 24;14:160
pubmed: 24655406
Lancet Infect Dis. 2005 Nov;5(11):685-94
pubmed: 16253886
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
PLoS Negl Trop Dis. 2016 Jun 27;10(6):e0004803
pubmed: 27348119
BMC Infect Dis. 2012 Sep 25;12:227
pubmed: 23009247
PLoS Negl Trop Dis. 2017 Jul 3;11(7):e0005726
pubmed: 28671945
Pediatr Infect Dis J. 2009 Jun;28(6):477-82
pubmed: 19483515
Trop Med Int Health. 2019 Mar;24(3):280-293
pubmed: 30582783
Hosp Pract (1995). 2017 Feb;45(1):9-15
pubmed: 28055287
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
PLoS Negl Trop Dis. 2018 Mar 19;12(3):e0006335
pubmed: 29554121
Lancet Infect Dis. 2019 May;19(5):510-518
pubmed: 30956111
N Engl J Med. 2015 Dec 10;373(24):2305-13
pubmed: 26650152
PLoS One. 2016 Feb 26;11(2):e0149960
pubmed: 26918456

Auteurs

Li Jun Thean (LJ)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

Adam Jenney (A)

College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji.

Daniel Engelman (D)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Melbourne Children's Global Health, Melbourne Children's Campus, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Lucia Romani (L)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Handan Wand (H)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Jyotishna Mudaliar (J)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Jessica Paka (J)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Tuliana Cua (T)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Sera Taole (S)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Aalisha Sahukhan (A)

Ministry of Health and Medical Services, Suva, Fiji.

Mike Kama (M)

Ministry of Health and Medical Services, Suva, Fiji.

Meciusela Tuicakau (M)

Ministry of Health and Medical Services, Suva, Fiji.

Joseph Kado (J)

Ministry of Health and Medical Services, Suva, Fiji.
Wesfarmers Centre for Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia, Australia.

Natalie Carvalho (N)

School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Margot Whitfeld (M)

Department of Dermatology, St. Vincent's Hospital, Sydney, New South Wales, Australia.
School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

John Kaldor (J)

Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Andrew C Steer (AC)

Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Melbourne Children's Global Health, Melbourne Children's Campus, The Royal Children's Hospital, Melbourne, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH